Evidence map›Paper›PMID 41986421›Full record

ArticleScientific reports2026

Deep learning for early detection of cerebral small vessel disease using self-supervised graph embeddings and retinal image analysis.

S Nandhini, K Vanitha

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S NandhiniDepartment of Computer Science and Engineering, Faculty of Engineering, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India. nandhiniphd07@gmail.com.
K VanithaDepartment of Computer Science and Engineering, Faculty of Engineering, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The primary driver or cause of cognitive decline and stroke is Cerebral Small Vessel Disease (CSVD), which currently requires neuroimaging tests, which are expensive to obtain and inaccessible in standard clinical settings. Low-cost retinal imaging techniques offer non-invasive assessments that mirror the condition of the brain’s small blood vessels (cerebral microvasculature). State-of-the-art diagnostic methods currently have no accessible, non-invasive, or cost-effective solution to identify CSVD at its earliest stages through visual assessment of retinal biomarkers. This study presents the Retino-Neuro Vision Transformer (RNV-T) framework as a proposed method to detect CSVD utilizing multimodality retinal imaging. The model system comprises five fundamental phases, beginning with Local Vascular Extraction (LVE), followed by Global Transformer-based Encoding (GTE), then proceeding to Graph-Based Relational Learning through Graph-based Convolutional Attention Network (G-CAN) before implementing Local-Global Attention Fusion (LGAF) as well as Optimized training procedures to obtain precise micro-vascular abnormality detection. The diagnostic performance of this model reaches 98.8% accuracy and shows 97.4% sensitivity along with 98.1% specificity, surpassing previous detection approaches. This diagnostic system represents a major leap forward in neuro-ophthalmic care because it enables early prediction of CSVD while expanding medical accessibility through retinal scans that are easy to conduct.

Indexed as

Cerebral Small Vessel DiseasesDeep LearningImage Processing, Computer-AssistedRetinaConvolutional Neural NetworksEarly DiagnosisHumansRetinal VesselsBlood vesselsCSVDNeuralNeuro-ophthalmicTransformers

Identifiers

PMID41986421
PMCPMC13243560

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.